DM
RYTM icon

Deerfield Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Deerfield Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-291,005
Closed -$1.21M – 135
2022
Q2 		$1.21M Hold
291,005
– – 0.02% 106
2022
Q1 		$3.35M Sell
291,005
-1,576,462
-84% -$13.8M 0.07% 93
2021
Q4 		$18.6M Sell
1,867,467
-122,158
-6% -$1.37M 0.39% 59
2021
Q3 		$26M Hold
1,989,625
– – 0.51% 56
2021
Q2 		$39M Hold
1,989,625
– – 0.69% 49
2021
Q1 		$42.3M Sell
1,989,625
-731,578
-27% -$21.2M 0.89% 37
2020
Q4 		$80.9M Buy
2,721,203
+824,156
+43% +$20.9M 1.6% 16
2020
Q3 		$41.1M Sell
1,897,047
-572,966
-23% -$13.1M 1% 30
2020
Q2 		$55.1M Sell
2,470,013
-561,552
-19% -$10.9M 1.6% 18
2020
Q1 		$46.1M Sell
3,031,565
-1,257,726
-29% -$22.5M 1.46% 21
2019
Q4 		$98.5M Buy
4,289,291
+1,700,000
+66% +$37.8M 3.14% 8
2019
Q3 		$55.9M Buy
2,589,291
+1,965,358
+315% +$42.2M 2.28% 8
2019
Q2 		$13.7M Buy
623,933
+332,928
+114% +$8.41M 0.49% 62
2019
Q1 		$7.98M Hold
291,005
– – 0.31% 64
2018
Q4 		$7.82M Sell
291,005
-74,684
-20% -$2.06M 0.31% 65
2018
Q3 		$10.7M Sell
365,689
-337,911
-48% -$10.7M 0.38% 67
2018
Q2 		$22M Buy
703,600
+121,590
+21% +$3.32M 0.77% 50
2018
Q1 		$11.6M Hold
582,010
– – 0.4% 78
2017
Q4 		$16.9M Buy
+582,010
New +$15.4M 0.67% 48

Other funds holding RYTM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management's RYTM Position: Q3 2022 in Review

Deerfield Management sold out of Rhythm Pharmaceuticals (RYTM) in Q3 2022, closing a stake of 291,005 shares — an estimated $1.21M sold.

Deerfield Management first reported a position in RYTM in Q4 2017 and held it in 19 quarters. The position peaked at $98.5M in Q4 2019. 101 funds tracked by Wall St. Rank hold RYTM as of Q3 2022.

  • Deerfield Management reported no remaining Rhythm Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Deerfield Management sold 291,005 Rhythm Pharmaceuticals shares in Q3 2022, an estimated $1.21M.
  • Deerfield Management first reported a position in Rhythm Pharmaceuticals in Q4 2017 and held it in 19 quarters.
  • Deerfield Management's Rhythm Pharmaceuticals position peaked at $98.5M in Q4 2019.
  • 101 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2022.

Based on Deerfield Management's 13F filing for Q3 2022, filed 14 Nov 2022.